Wearable Continuous Vital Sign Monitoring Study (WARD-AMS) to Detect Clinical Deterioration in Postoperative General Surgery Patients: Protocol for a Randomized Controlled Trial
The WARD-AMS study is among the first prospective, randomized evaluations of continuous vital sign monitoring in real-world ward settings looking at clinical outcomes and user experience. By integrating clinical outcomes, alarm analytics, and stakeholder experiences, it aims to provide a comprehensive understanding of the benefits, limitations, and implementation challenges of continuous monitoring. Findings from this study will inform strategies to optimize response to early clinical deterioration, reducing alarm fatigue and embedding new technologies into existing routine ward practice.
Institutions
- General Electric (Spain) (ES)
- Chelsea and Westminster Hospital NHS Foundation Trust (GB)
- Hammersmith Hospital (GB)
- Lung Institute (US)
- Imperial College London (GB)
Publication Details
- Journal
- JMIR Research Protocols
- Published
- 2025-12-08
- DOI
- https://doi.org/10.2196/81558
- Citations
- 1
- Primary Topic
- Healthcare Technology and Patient Monitoring
- Type
- article
- Field-Weighted Citation Impact
- 2.01